Capitolis Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Capitolis Advisors LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$79.4 - $116.36 $356,744 - $522,805
-4,493 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$86.42 - $109.81 $4.93 Million - $6.26 Million
-57,000 Reduced 92.69%
4,493 $473,000
Q3 2021

Nov 12, 2021
BUY
$91.91 - $110.37 $5.65 Million - $6.79 Million
61,493 New
61,493 $6.95 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Capitolis Advisors LLC Portfolio

Follow Capitolis Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email